Sting Relief Swab

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Sting Relief Swab
Generic name: BENZOCAINE
Manufacturer: 4 Visions LLC
Product type: HUMAN OTC DRUG
SPL set ID: 4f76a8c5-fde6-eee0-e063-6394a90a09f8
SPL ID: 4f76b28a-ca3f-5438-e063-6394a90a293c
Version: 1
Effective date: 2026-04-14
Source export date: 2026-09-28
Source partition: 3
Source file: https://download.open.fda.gov/drug/label/drug-label-0003-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/fd09911bd1bc81f7f2faeb048e63855fe224e494376ae919a0035190e315c050/drug-label-0003-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:19:34

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 12 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		Sting Relief Swab	openfda.brand_name
generic name		BENZOCAINE	openfda.generic_name
manufacturer name		4 Visions LLC	openfda.manufacturer_name
ndc	package	87251-010-01	openfda.package_ndc
ndc	product	87251-010	openfda.product_ndc
ndc11	package	87251001001	derived:openfda.package_ndc
rxcui		1037117	openfda.rxcui
spl id		4f76b28a-ca3f-5438-e063-6394a90a293c	id
spl set id		4f76a8c5-fde6-eee0-e063-6394a90a09f8	set_id
unii		U3RSY48JW5	openfda.unii
unii		L7T10EIP3A	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only do not use in the eyes not for prolonged use do not apply other medications to the same affected areas unless advised by a doctor Stop use and ask a doctor if condition for this preparation is used persists, or if a rash, irritation or allergic reaction develops.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.